6th CKD Summit – Chronic Kidney Disease Drug Development

19-21 March, 2024
Boston, MA

ENYO Pharma will attend the 6th Chronic Kidney Disease Drug Development Summit, an industry forum sharing cross-industry insight to bring effective therapies to patients suffering from kidney diseases expanding also to rare renal disorders.

https://ckd3-summit.com/

Read more »

Published on 24/11/2023

EASL – The International Liver Congress 2016

13-17 April 2016

Barcelona, Spain

Every year in April, scientific and medical experts from a broad range of fields including hepatology, gastroenterology, internal medicine, cell biology, transplant surgery, infectious diseases, microbiology and virology, pharmacology, pathology and radiology and imaging come together from around the world to learn about the latest in liver research.

http://ilc-congress.eu/

Read more »

Published on 28/01/2016

ENYO Pharma strengthens its arsenal of hepatitis B potential therapies

Lyon, November 25, 2015 – ENYO Pharma, a biopharmaceutical company focused on developing treatments for acute and chronic viral infections, is announcing that it has obtained a license to a key patent enabling it to use agonists of the farnesoid X receptor (FXR) as hepatitis B treatments.

Read more »

Published on 25/11/2015